Who owns ACTINIUM PHARMACEUTICALS INC?
- Ticker: ATNM
- CUSIP Number: 00507w206
Tip: Access positions for across all investors
Analyze quarterly positions in Actinium Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Actinium Pharmaceuticals stock
Who bought or sold ACTINIUM PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 1.9M | $3.6M | 100% | Sep 2024 |
|
| BlackRock | 1.9M | $14M | 10% | Jun 2024 |
|
| Vanguard Group | 1.5M | $11M | 2% | Jun 2024 |
|
| Geode Capital Management | 686k | $1.3M | 3% | Sep 2024 |
|
| State Street Corporation | 610k | $4.5M | 11% | Jun 2024 |
|
| Acadian Asset Management | 454k | $851k | 100% | Sep 2024 |
|
| AQR Capital Management | 359k | $676k | 100% | Sep 2024 |
|
| Northern Trust | 240k | $451k | 4% | Sep 2024 |
|
| Thomas Stevens, CFA" | 171k | $322k | 100% | Sep 2024 |
|
| Verition Fund Management | 170k | $1.3M | -66% | Jun 2024 |
|
| Nuveen Asset Management | 170k | $1.3M | 71% | Jun 2024 |
|
| Renaissance Technologies | 127k | $239k | 561% | Sep 2024 |
|
| Morgan Stanley | 94k | $695k | 33% | Jun 2024 |
|
| Brandywine Global Investment Management | 90k | $169k | -30% | Sep 2024 |
|
| Citadel Advisors | 87k | $163k | -29% | Sep 2024 |
|
| Bridgeway Capital Management | 84k | $621k | 0% | Jun 2024 |
|
| Charles Schwab Investment Management | 72k | $136k | -14% | Sep 2024 |
|
| Bank of New York Mellon | 66k | $123k | -24% | Sep 2024 |
|
| Creative Financial Designs | 64k | $120k | 183% | Sep 2024 |
|
| Dimensional Fund Advisors | 51k | $96k | -54% | Sep 2024 |
|
| Royce & Associates | 50k | $94k | 0% | Sep 2024 |
|
| Squarepoint Ops | 48k | $356k | 100% | Jun 2024 |
|
| Bank of America Corporation | 45k | $84k | 7% | Sep 2024 |
|
| Barclays | 43k | $81k | 323% | Sep 2024 |
|
| Jane Street | 41k | $77k | -37% | Sep 2024 |
|
| Goldman Sachs Group | 40k | $298k | 261% | Jun 2024 |
|
| Rhumbline Advisers | 39k | $73k | -2% | Sep 2024 |
|
| Marshall Wace | 33k | $62k | -87% | Sep 2024 |
|
| Snowden Capital Advisors | 31k | $59k | 0% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 24k | $45k | 32% | Sep 2024 |
|
| Susquehanna International | 23k | $42k | -81% | Sep 2024 |
|
| Citigroup | 22k | $41k | 230% | Sep 2024 |
|
| Interchange Capital Partners | 20k | $37k | 100% | Sep 2024 |
|
| Intrepid Financial Planning Group | 19k | $36k | -5% | Sep 2024 |
|
| Man Group | 16k | $31k | 100% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 16k | $31k | 11% | Sep 2024 |
|
| Wells Fargo & Company | 15k | $27k | -2% | Sep 2024 |
|
| Am Investment Strategies | 14k | $27k | 6% | Sep 2024 |
|
| Alliancebernstein | 14k | $103k | 100% | Jun 2024 |
|
| Virtu Financial | 14k | $26k | -34% | Sep 2024 |
|
| Jpmorgan Chase & Co | 14k | $26k | -1% | Sep 2024 |
|
| Manufacturers Life Insurance Company | 13k | $92k | 100% | Jun 2024 |
|
| Invesco | 12k | $23k | 1% | Sep 2024 |
|
| Advisor Group Holdings | 10k | $19k | 1% | Sep 2024 |
|
| Royal Bank of Canada | 8.2k | $0 | 1% | Sep 2024 |
|
| New York State Common Retirement Fund | 6.7k | $13k | 0% | Sep 2024 |
|
| Tower Research Capital | 5.3k | $39k | 124% | Jun 2024 |
|
| CWM | 3.2k | $6.0k | 3040% | Sep 2024 |
|
| California State Teachers Retirement System | 2.2k | $4.1k | 0% | Sep 2024 |
|
| Summit Investment Advisors | 2.1k | $4.0k | 0% | Sep 2024 |
|
| Federated Investors | 2.0k | $3.8k | 100% | Sep 2024 |
|
| Amalgamated Bank | 877.00 | $2.0k | 0% | Sep 2024 |
|
| National Bank Of Canada /fi/ | 855.00 | $1.6k | 0% | Sep 2024 |
|
| BFSG | 500.00 | $940.000000 | 0% | Sep 2024 |
|
| True Wealth Design | 472.00 | $888.020800 | 100% | Sep 2024 |
|
| Russell Investments | 466.00 | $3.4k | 100% | Jun 2024 |
|
| Capital Performance Advisors | 437.00 | $821.997000 | 100% | Sep 2024 |
|
| Hartford Financial Management | 266.00 | $501.011000 | 0% | Sep 2024 |
|
| Cornerstone Planning Group | 252.00 | $474.012000 | 100% | Sep 2024 |
|
| NISA Investment Advisors | 232.00 | $435.997600 | 355% | Sep 2024 |
|
| SRS Capital Advisors | 126.00 | $237.006000 | 0% | Sep 2024 |
|
| Northwestern Mutual Wealth Management Company | 107.00 | $200.999500 | 0% | Sep 2024 |
|
| Capital Advisors | 63.00 | $0 | 100% | Sep 2024 |
|
| Sterling Capital Management | 31.00 | $58.001000 | 100% | Sep 2024 |
|
| Aviso Financial | 30.00 | $219.000000 | 100% | Jun 2024 |
|
| FNY Investment Advisers | 23.00 | $0 | 100% | Sep 2024 |
|
Who sold out of Actinium Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Schonfeld Strategic Advisors | Jun 2024 | 142k | $1.0M |
| D. E. Shaw & Co | Jun 2024 | 29k | $217k |
| Millennium Management | Jun 2024 | 21k | $156k |
| Corton Capital | Jun 2024 | 20k | $150k |
| American Century Companies | Jun 2024 | 18k | $133k |
| MetLife Investment Advisors | Jun 2024 | 15k | $113k |
| National Asset Management | Jun 2024 | 13k | $96k |
| Perritt Capital Management | Jun 2024 | 12k | $89k |
| Ing Investment Management | Jun 2024 | 11k | $79k |
| Qube Research & Technologies | Mar 2024 | 3.2k | $25k |
| nVerses Capital | Jun 2024 | 2.2k | $16k |
| Steward Partners Investment Advisory | Mar 2024 | 100.00 | $783.000000 |